Chenye Mou
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An explainable multimodal machine learning model for diagnosing disorders of consciousness: evidence from a large multicenter Chinese cohort.
Journal: Journal of translational medicine
Published: February 26, 2026
Altered oral microbiomes in patients with prolonged disorders of consciousness.
Journal: Journal of oral microbiology
Published: November 24, 2025
Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.
Journal: Nature cell biology
Published: December 16, 2024
Protection of Si Nanowires against Aβ Toxicity by the Inhibition of Aβ Aggregation.
Journal: Molecules (Basel, Switzerland)
Published: March 26, 2024
Alterations in metabolome and lipidome in patients with in-stent restenosis.
Journal: CNS neuroscience & therapeutics
Published: February 24, 2024
Neuroprotective Effects of an Edible Pigment Brilliant Blue FCF against Behavioral Abnormity in MCAO Rats.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 06, 2022
Tolcapone Derivative (Tol-D) Inhibits Aβ42 Fibrillogenesis and Ameliorates Aβ42-Induced Cytotoxicity and Cognitive Impairment.
Journal: ACS chemical neuroscience
Published: February 11, 2022
Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Journal: Bioorganic chemistry
Published: April 01, 2021
Fascaplysin Derivatives Are Potent Multitarget Agents against Alzheimer's Disease: in Vitro and in Vivo Evidence.
Journal: ACS chemical neuroscience
Published: October 23, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026